January 13, 2026 at 12:00 PM UTCProxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 million in seed funding, which will help it collect better data and eventually develop potential drug candidates.The financing round was led by Data Collective Venture Capital, with additional investors including Nvidia Corp., Thermo Fisher Scientific Inc., Roivant Sciences Ltd., and Braidwell LP....